The Interpretation of Guidelines for the Management of Candidiasis from Infectious Diseases Society of America 2009_Chinese Journal of Evidence-Based Medicine

Authors：

 ZHOUYing-jie ,  LIGuang-hui

Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai 200040, China;

Corresponding author：

LIGuang-hui, Email: liguanghui@fudan.edu.cn

Keywords：

Candidiasis; Invasive fungal disease; Antifungal therapy; Clinical practice guideline

DOI：

10.7507/1672-2531.20160005

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： ZHOUYing-jie, LIGuang-hui. The Interpretation of Guidelines for the Management of Candidiasis from Infectious Diseases Society of America 2009. Chinese Journal of Evidence-Based Medicine, 2016, 16(1): 20-22. doi: 10.7507/1672-2531.20160005 Copy

1.	Fridkin SK. The changing face of fungal infections in health care settings. Clin Infect Dis, 2005, 41(10): 1455-1460.
2.	Pfaller MA, Diekema DJ, Sheehan DJ. Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing. Clin Microbiol Rev, 2006, 19(2): 435-447.
3.	Clinical and Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of yeasts: Approved standard, 3rd. ed. CLSI document M27-A3. Wayne, PA: CLSI, 2008.
4.	Pappas PG, Kauffman CA, Andes D, et al. Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis, 2009, 48(5): 503-535.

Chinese Journal of Evidence-Based Medicine

The Interpretation of Guidelines for the Management of Candidiasis from Infectious Diseases Society of America 2009

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content